Products & ReviewLife Sciences

OrganoPlate® Graft

MIMETAS B.V.Available: Worldwide

The OrganoPlate® Graft is the first in vitro cell culture platform that allows vascularization of 3D tissues like spheroids, organoids, and tumors in vitro.

MIMETAS B.V.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Average Rating 4.0

|1Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Inexhaustible combinatorial uses.

 

Average Rating 4.0

Application Area:

Early drug discovery

Provides a unique intermediary between research projects and compound screening. The format of the plate provides the flexibility to support multiple cell types and configurations. Well designed for multi-modes of microscopy and the quantification of multiple reagents.

Review Date: 10 Feb 2020 | MIMETAS B.V.

The OrganoPlate® Graft is the first in vitro cell culture platform that allows vascularization of 3D tissues like spheroids, organoids, and tumors in vitro.

The OrganoPlate® Graft incorporates the unique technology developed by MIMETAS to grow functional microvessels in a chip to create a microvascular bed.

Tissue placed onto this bed is connected to the system of human blood vessels, achieving in vitro vascularization. This uniquely facilitates perfusion of the tissue and allows drug administration through the vasculature.

Product Overview

Links